(Q45855775)

English

Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

0 references

0 references

author name string

Triantaphyllopoulos KA

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

Williams RO

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

Tailor H

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

Chernajovsky Y

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

publication date

1 January 1999

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

Arthritis & Rheumatology

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

42

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

90-99

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Clinical trials of interferons in multiple sclerosis. What have we learned?

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Mechanisms of action of interferon-beta in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Gene therapy for rheumatoid arthritis. Theoretical considerations.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

An oligodendrocyte precursor cell line from rat optic nerve

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Production of high-titer helper-free retroviruses by transient transfection

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Efficient constitutive production of human fibroblast interferon by hamster cells transformed with the IFN-beta 1 gene fused to an SV40 early promoter.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Enhanced NK cell activity in mice injected with interferon and interferon inducers

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C90%3A%3AAID-ANR12%3E3.0.CO%3B2-A

21 January 2018

Identifiers

10.1002/1529-0131(199901)42:1<90::AID-ANR12>3.0.CO;2-A

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/9920019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45855775&oldid=2086707292"